Why Quitting Cannabis Wrecks Your Sleep — and Why It Gets Better
Cannabis, Cannabinoids, and Sleep: a Review of the Literature.
Bottom Line
The most-cited cannabis sleep review distinguished THC from CBD, mapped the withdrawal-sleep-relapse cycle, and showed that sleep disruption is the #1 withdrawal symptom and strongest predictor of relapse.
Why It Matters
Sleep is one of the most common reasons people give for using cannabis, yet in 2017 the research base was remarkably thin. This review made that gap visible. The THC finding was particularly important to surface: something that helps you fall asleep faster but degrades sleep architecture over time is a trade-off most users probably aren't aware of. The CBD findings, while preliminary, opened a research direction that has since attracted more attention. The distinction between "helps you fall asleep" and "gives you good sleep" is one that this review drew clearly.
The Backstory
Kimberly Babson spent her career at the VA studying two things that destroy veterans: sleep problems and substance use. She worked at the National Center for PTSD in Palo Alto, where the intersection of these two domains — cannabis users who can't sleep, sleep-deprived patients who turn to cannabis — was a daily clinical reality.
In 2017, she and her colleagues published what would become the most-cited review of cannabis and sleep in the psychiatric literature. It covered everything from insomnia to sleep apnea to PTSD nightmares. But the findings that resonated most — the ones that people still search for years later — were about what happens when you stop.
The Review
Published in Current Psychiatry Reports, Babson's review built on Gates' 2014 systematic review with three years of additional evidence and a more clinical focus. Where Gates asked "what does the evidence show?" in aggregate, Babson asked "what does the evidence mean for specific sleep disorders?" — and crucially, for people trying to quit.
The review covered five territories: cannabis and insomnia, cannabis and obstructive sleep apnea, cannabinoids and PTSD nightmares, CBD for REM sleep behavior disorder, and the withdrawal-sleep connection. The authors' conclusion was admirably honest: "Research on cannabis and sleep is in its infancy and has yielded mixed results."
But within that mixed picture, certain findings were clear enough to change how clinicians think about cannabis and sleep.
THC vs. CBD: Different Molecules, Different Sleep
This distinction — that THC and CBD have opposing effects on sleep — was one of the review's most important contributions. Prior reviews had often lumped "cannabis" into a single category. Babson's team drew the line clearly: THC is a sedative that degrades sleep quality over time; CBD may actually improve it, but through a completely different mechanism (anxiety reduction rather than direct sedation) and without the REM suppression that makes THC problematic.
For the cannabis-for-sleep debate, this distinction matters enormously. A high-THC indica edible and a CBD tincture are not the same intervention, and the evidence suggests they have fundamentally different effects on sleep architecture.
The Withdrawal Problem
This is where the review hit hardest, and why the pillar article titles this study "Cannabis Cessation and Vivid Dreams." The withdrawal-sleep connection is the most clinically important finding in the entire cannabis-sleep literature.
~76%
of regular cannabis users report sleep disturbance as a withdrawal symptom when they stop — making it the single most common withdrawal complaint, ahead of irritability, anxiety, and appetite changes.
Sleep disruption during cannabis withdrawal is also the strongest predictor of relapse. People don't go back to cannabis because they miss the high. They go back because they can't sleep.
Babson et al. (2017), citing Budney et al. (2004) and others
The mechanism is straightforward: THC suppresses REM sleep. The brain compensates by upregulating REM-generating mechanisms. When THC is removed, those mechanisms fire without opposition. The result is REM rebound — a dramatic surge in dream vividness, frequency, and emotional intensity that can persist for weeks after the last use.
This timeline — the surge, the peak, the gradual normalization — is what we map in our sleep recovery timeline and withdrawal dreams guide. The Babson review consolidated the evidence that made those guides possible.
The Relapse Trap
The clinical significance of withdrawal-related sleep disruption goes beyond discomfort. Babson's review highlighted research showing that sleep problems during cannabis cessation are one of the strongest predictors of relapse. The logic is devastating in its simplicity:
You quit cannabis. You can't sleep. After days of insomnia and terrifying vivid dreams, you use cannabis again — and the insomnia resolves immediately. The negative reinforcement is powerful and immediate. Cannabis becomes the solution to the problem cannabis created.
This is why our first week quitting guide emphasizes sleep management so heavily, and why understanding the withdrawal timeline — knowing that the sleep disruption has a predictable endpoint — is itself therapeutic. You're not broken. Your brain is recalibrating. It has a timeline. Babson's review provided the evidence base for that reassurance.
Beyond Insomnia: Surprising Sleep Findings
The review wasn't just about cessation. It covered emerging evidence for cannabinoids across several sleep disorders:
Obstructive sleep apnea: Synthetic cannabinoids (dronabinol, nabilone) showed short-term benefit for sleep apnea by modulating serotonin-mediated breathing pauses during sleep. This was a genuinely surprising finding — cannabinoids affecting respiratory control during sleep was not an intuitive prediction.
REM sleep behavior disorder: CBD showed promise in early case reports for RBD, a condition where people physically act out their dreams (often violently) during REM sleep. CBD appeared to reduce these episodes without suppressing REM itself — a targeted effect that THC cannot achieve.
PTSD nightmares: The review incorporated evidence from Jetly's nabilone trial and clinical experience, confirming that synthetic cannabinoids can suppress trauma-related nightmares through REM modulation. For veterans who hadn't slept through the night in years, this remained one of the most compelling clinical applications.
Chronic pain and sleep: Cannabinoids may improve sleep in chronic pain patients — not by being better sleep aids, but by reducing the pain that was disrupting sleep in the first place. The sleep improvement was a secondary benefit of pain management, not a primary pharmacological effect.
The State of the Evidence
Babson's team was careful to frame all findings as preliminary. The phrase "in its infancy" appears repeatedly. The authors identified the same structural problems Gates had flagged three years earlier: small samples, heterogeneous products, inconsistent outcome measures, short study durations, and the near-impossibility of blinding participants to a psychoactive drug.
But the review also pointed forward. By distinguishing between cannabinoids rather than lumping them together, by separating acute from chronic effects, and by connecting withdrawal-related sleep disruption to relapse risk, Babson's review transformed the cannabis-sleep conversation from a simple yes/no question into a nuanced clinical framework. The answer isn't "cannabis helps you sleep" or "cannabis hurts your sleep." The answer is: which cannabinoid, at what dose, for how long, for what specific sleep problem, and what happens when you stop?
Key Takeaways
Cannabis, Cannabinoids, and Sleep: a Review of the Literature
Babson KA, Sottile J, Morabito D () · Current Psychiatry Reports
Frequently Asked Questions
Cite this study
Babson, Kimberly A; Sottile, James; Morabito, Danielle. (2017). Cannabis, Cannabinoids, and Sleep: a Review of the Literature.. Current psychiatry reports, 19(4), 23. https://doi.org/10.1007/s11920-017-0775-9